Biomedical Innovation Commercialization Readiness Program, March 5 – April 9

Luiz Bertassoni created a process to engineer blood vessels

Do you have an idea for an innovative technology but don’t know where to start? Biomedical Innovation Commercialization Readiness Program (BIP Corp) is a five-week experiential course designed to help you and your team assess and validate your biomedical technology.

March 5 – April 9: Entirely virtual.
View the full course details and dates.

Gain the basic knowledge and tools to initiate innovation and commercialization of your technology, and develop a competitive business case to secure funding, partnerships and further research opportunities.

Offered at no cost by OHSU’s Oregon Clinical and Translational Research Institute (OCTRI) and OHSU Collaborations & Entrepreneurship.

This course is ideal for faculty, researchers, students and industry scientists with an early-stage idea or team with an idea. BIP Corp instructors are experts from across the bioscience industry and academia with experience bringing healthcare technologies and therapeutics to market.

Pictured above: Luiz Bertassoni, D.D.S., Ph.D., holds one of the teeth used to create a new process to engineer artificial blood vessels, which are used to help regenerate teeth. He has worked extensively with OHSU Technology Transfer to protect and commercialize several of his inventions and was awarded funds through the 2019 Biomedical Innovation Program for his BoneMimetics drug discovery program. (OHSU/Kristyna Wentz-Graff)